107 related articles for article (PubMed ID: 5755808)
1. Peroral therapy with cytosine arabinoside. Preliminary laboratory and clinical findings.
Goldenberg DM; Schricker KT; von der Emde J; Sögtrop HH
Arzneimittelforschung; 1968 Jun; 18(6):712-4. PubMed ID: 5755808
[No Abstract] [Full Text] [Related]
2. Cytosine arabinoside (NSC-63878)--clinical brochure.
Livingston RB; Carter SK
Cancer Chemother Rep 3; 1968 Dec; 1(1):179-205. PubMed ID: 4989814
[No Abstract] [Full Text] [Related]
3. Phase II study of cytosine arabinoside in advanced large bowel cancer.
Cullinan SA; O'Connell MJ; Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ; Frytak S; Rubin J
Cancer Treat Rep; 1977 Dec; 61(9):1725-6. PubMed ID: 340037
[No Abstract] [Full Text] [Related]
4. Scheduling of arabinosylcytosine and 6-thioguanine therapy.
LePage GA; White SC
Cancer Res; 1973 May; 33(5):946-9. PubMed ID: 4703126
[No Abstract] [Full Text] [Related]
5. Effect of combined therapy with cytosine arabinoside (NSC-63878) and l,3-bis-(2-chloroethyl)-1-nitrosourea (NSC-409962) on sarcoma 180 and L1210 in vivo.
Mizuno NS; Humphrey EW
Cancer Chemother Rep; 1969 Sep; 53(4):215-21. PubMed ID: 5384462
[No Abstract] [Full Text] [Related]
6. Chemotherapy in alimentary tract malignomas.
Queisser W; Heim ME
Hepatogastroenterology; 1981 Oct; 28(5):276-83. PubMed ID: 6212524
[No Abstract] [Full Text] [Related]
7. Criteria associated with destruction of leukemia and solid tumor cells in animals.
Skipper HE
Cancer Res; 1967 Dec; 27(12):2636-45. PubMed ID: 6082300
[No Abstract] [Full Text] [Related]
8. Drug control of Ara-C-resistant tumor cells.
Schabel FM; Skipper HE; Trader MW; Brockman RW; Laster WR; Corbett TH; Griswold DP
Med Pediatr Oncol; 1982; 10 Suppl 1():125-48. PubMed ID: 7162459
[No Abstract] [Full Text] [Related]
9. [Clinical and animal experiment studies on the cell-cycle arrest using cytosine arabinoside in leukemias].
Büchner T; Barlogie B; Hiddemann W; Hofschröer J; Metz U; Ortheil NB; Kamanabroo D; Asseburg U
Verh Dtsch Ges Inn Med; 1975; 81():1112-4. PubMed ID: 1065151
[No Abstract] [Full Text] [Related]
10. Synthesis of 1-beta-L-arabinofuranosylcytosine, the enantiomer of cytosine arabinoside.
Tolman RL; Robins RK
J Med Chem; 1971 Nov; 14(11):1112. PubMed ID: 5286580
[No Abstract] [Full Text] [Related]
11. Possibilities and limitations of the cytostatic treatment of gastrointestinal carcinoma.
Trux F
Hepatogastroenterology; 1982 Jun; 29(3):130-3. PubMed ID: 7049880
[No Abstract] [Full Text] [Related]
12. [Combined application of drugs in cancer chemotherapy with special reference to the combination of mitomycin C, 5-fluorouracil, and cytosine arabinoside].
Nakao I; Furue H; Furukawa K; Kanko T; Harashima S
Gan No Rinsho; 1972 Feb; 18(2):138-43. PubMed ID: 5063156
[No Abstract] [Full Text] [Related]
13. [Effect of polychemotherapy of cancer of the digestive organs].
Singer Z; Kobylińska-Scieszkowa M; Dzieza-Lalowicz I; Starzewska H; Rogoń Z; Gejsler A
Pol Tyg Lek; 1980 Sep; 35(38):1453-5. PubMed ID: 7465441
[No Abstract] [Full Text] [Related]
14. Sequential chemotherapy with cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in mice with advanced leukemia L1210.
Hoffman GS; Kline I; Gang M; Tyrer DD; Goldin A; Mantel N; Venditti JM
Cancer Chemother Rep; 1969 Oct; 53(5):265-71. PubMed ID: 5377613
[No Abstract] [Full Text] [Related]
15. High-dose cytosine arabinoside (Ara-C) in colorectal cancer.
Kanojia M; Kantarjian H; Ajani J; Barlogie B
Br J Cancer; 1983 Dec; 48(6):869-71. PubMed ID: 6652028
[No Abstract] [Full Text] [Related]
16. A clinical evaluation of a prolonged schedule of cytosine arabinoside (NSC63878).
Burke PJ; Owens AH; Colsky J; Shnider BI; Edmonson JH; Schilling A; Brodovsky HS; Wallace HJ; Hall TC
Cancer Res; 1970 May; 30(5):1512-5. PubMed ID: 5426952
[No Abstract] [Full Text] [Related]
17. A computer model for tumor growth and chemotherapy, and its application to L1210 leukemia treated with cytosine arabinoside (NSC-63878).
Shackney SE
Cancer Chemother Rep; 1970 Dec; 54(6):399-429. PubMed ID: 5527022
[No Abstract] [Full Text] [Related]
18. Enhancement of the cancer chemotherapeutic effect of cytosine arabinoside entrapped in liposomes on mouse leukemia L-1210.
Kobayashi T; Tsukagoshi S; Sakurai Y
Gan; 1975 Dec; 66(6):719-20. PubMed ID: 1225724
[No Abstract] [Full Text] [Related]
19. [Chemotherapy of gastrointestinal cancer in the advanced stage with a combination of 5-fluorouracil, adriamycin, mitomycin C (FAM). A non-controlled study].
Grieco A; Lasorella A; Astone A; Vagliviello L; Bartoloni C; Barone C
Clin Ter; 1984 Aug; 110(4):353-8. PubMed ID: 6237871
[No Abstract] [Full Text] [Related]
20. Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213.
Rivera G; Avery T; Roberts DW
Eur J Cancer (1965); 1975 Sep; 11(9):639-47. PubMed ID: 1220978
[No Abstract] [Full Text] [Related]
[Next] [New Search]
